Chloroquine efficacy for Plasmodium vivax in Myanmar in populations with high genetic diversity and moderate parasite gene flow

BACKGROUND: Plasmodium vivax malaria remains a major public health burden in Myanmar. Resistance to chloroquine (CQ), the first-line treatment for P. vivax, has been reported in the country and has potential to undermine local control efforts. METHODS: Patients over 6 years of age with uncomplicated...

Descripción completa

Detalles Bibliográficos
Autores principales: Htun, Myo Win, Mon, Nan Cho Nwe, Aye, Khin Myo, Hlaing, Chan Myae, Kyaw, Myat Phone, Handayuni, Irene, Trimarsanto, Hidayat, Bustos, Dorina, Ringwald, Pascal, Price, Ric N., Auburn, Sarah, Thriemer, Kamala
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5504659/
https://www.ncbi.nlm.nih.gov/pubmed/28693552
http://dx.doi.org/10.1186/s12936-017-1912-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5504659/
https://www.ncbi.nlm.nih.gov/pubmed/28693552
http://dx.doi.org/10.1186/s12936-017-1912-y

Ejemplares similares